Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › GH

FARALLON CAPITAL MANAGEMENT, L.L.C. position in GH

GUARDANT HEALTH INC · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 279,700 shares of GH (GUARDANT HEALTH INC) in its Q3 2026 13F filing — a position valued at US$49.9M, representing 0.22% of its reported portfolio and ranking #41 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed GH holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)279.70K sh
Reported value held$49.89M
Portfolio Weight0.22%
First reportedQ2 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s GH position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in GH in Q2 2025 at 8,000 shares (US$416K). The position peaked in Q3 2026 at 279,700 shares, worth US$49.9M. Across 6 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 279,700 shares valued at US$49.9M — a reduction of -42,500 shares quarter over quarter.. Notable position changes include a 1262% increase in Q4 2025 (shares fell 10% over the following quarter), a 93% trim in Q1 2026 (shares rose 62% over the following quarter), a 3928% increase in Q2 2026 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 8.00K $416.32K New
Q3 2025 8.00K $499.84K Hold
Q4 2025 109.00K $11.13M Add
Q1 2026 8.00K $738.96K Reduce
Q2 2026 322.20K $48.34M Add
Q3 2026 279.70K $49.89M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GH and 13F data

GH (GUARDANT HEALTH INC) is a Health Care company. 60 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$500.4M), FEDERATED HERMES, INC. (US$445.6M), EVENTIDE ASSET MANAGEMENT, LLC (US$331.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GH

All GH fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held GH?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed GH holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in GH?

As of Q3 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 279.70K shares of GH (GUARDANT HEALTH INC), valued at $49.89M, representing 0.22% of its reported portfolio and ranking #41.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling GH?

In the latest 13F filing (Q3 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. reduced its position in GH. The position peaked in Q3 2026 at 279.70K shares.

Which other funds hold GH?

Other major institutional holders of GH include Deep Track Capital, LP, FEDERATED HERMES, INC., EVENTIDE ASSET MANAGEMENT, LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.